425 related articles for article (PubMed ID: 27378567)
21. Augmentation of cGMP/PKG pathway and colonic motility by hydrogen sulfide.
Nalli AD; Bhattacharya S; Wang H; Kendig DM; Grider JR; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2017 Oct; 313(4):G330-G341. PubMed ID: 28705807
[TBL] [Abstract][Full Text] [Related]
22. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
[TBL] [Abstract][Full Text] [Related]
23. Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation.
Jones AW; Durante W; Korthuis RJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):85-91. PubMed ID: 20605906
[TBL] [Abstract][Full Text] [Related]
24. Chronological Change of Vascular Reactivity to cGMP Generators in the Balloon-Injured Rat Carotid Artery.
Tawa M; Shimosato T; Sakonjo H; Masuoka T; Nishio M; Ishibashi T; Okamura T
J Vasc Res; 2019; 56(3):109-116. PubMed ID: 31085923
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing the soluble guanylate cyclase heme redox state in blood vessels.
Tawa M; Okamura T
Vascul Pharmacol; 2022 Aug; 145():107023. PubMed ID: 35718342
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.
Ghosh A; Stasch JP; Papapetropoulos A; Stuehr DJ
J Biol Chem; 2014 May; 289(22):15259-71. PubMed ID: 24733395
[TBL] [Abstract][Full Text] [Related]
27. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation.
Lin Y; Chen Y; Zhu N; Zhao S; Fan J; Liu E
Biomed Pharmacother; 2016 Oct; 83():466-476. PubMed ID: 27427853
[TBL] [Abstract][Full Text] [Related]
28. Hydrogen sulfide donor, NaHS, stimulates ANP secretion via the K
Yu L; Park BM; Ahn YJ; Lee GJ; Kim SH
Peptides; 2019 Jan; 111():89-97. PubMed ID: 29684589
[TBL] [Abstract][Full Text] [Related]
29. Vasorelaxation elicited by endogenous and exogenous hydrogen sulfide in mouse mesenteric arteries.
Hart JL
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):551-564. PubMed ID: 31713651
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.
Meurer S; Pioch S; Pabst T; Opitz N; Schmidt PM; Beckhaus T; Wagner K; Matt S; Gegenbauer K; Geschka S; Karas M; Stasch JP; Schmidt HH; Müller-Esterl W
Circ Res; 2009 Jul; 105(1):33-41. PubMed ID: 19478201
[TBL] [Abstract][Full Text] [Related]
31. Thiol-Based Redox Modulation of Soluble Guanylyl Cyclase, the Nitric Oxide Receptor.
Beuve A
Antioxid Redox Signal; 2017 Jan; 26(3):137-149. PubMed ID: 26906466
[TBL] [Abstract][Full Text] [Related]
32. Vasorelaxant Effect of Novel Nitric Oxide-Hydrogen Sulfide Donor Chalcone in Isolated Rat Aorta: Involvement of cGMP Mediated sGC and Potassium Channel Activation.
Sherikar A; Dhavale R; Bhatia M
Curr Mol Pharmacol; 2020; 13(2):126-136. PubMed ID: 31654520
[TBL] [Abstract][Full Text] [Related]
33. Aging does not affect soluble guanylate cyclase redox state in mouse aortas.
Shimosato T; Tawa M; Iwasaki H; Imamura T; Okamura T
Physiol Rep; 2016 May; 4(10):. PubMed ID: 27233303
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
[TBL] [Abstract][Full Text] [Related]
35. Potential role of mitochondrial superoxide decreasing ferrochelatase and heme in coronary artery soluble guanylate cyclase depletion by angiotensin II.
Patel D; Alhawaj R; Kelly MR; Accarino JJ; Lakhkar A; Gupte SA; Sun D; Wolin MS
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1439-47. PubMed ID: 27037373
[TBL] [Abstract][Full Text] [Related]
36. Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide.
Fernhoff NB; Derbyshire ER; Underbakke ES; Marletta MA
J Biol Chem; 2012 Dec; 287(51):43053-62. PubMed ID: 23093402
[TBL] [Abstract][Full Text] [Related]
37. Structure and Activation of Soluble Guanylyl Cyclase, the Nitric Oxide Sensor.
Montfort WR; Wales JA; Weichsel A
Antioxid Redox Signal; 2017 Jan; 26(3):107-121. PubMed ID: 26979942
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
39. Irreversible Activation and Stabilization of Soluble Guanylate Cyclase by the Protoporphyrin IX Mimetic Cinaciguat.
Kollau A; Opelt M; Wölkart G; Gorren ACF; Russwurm M; Koesling D; Mayer B; Schrammel A
Mol Pharmacol; 2018 Feb; 93(2):73-78. PubMed ID: 29138269
[TBL] [Abstract][Full Text] [Related]
40. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation.
Sayed N; Baskaran P; Ma X; van den Akker F; Beuve A
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12312-7. PubMed ID: 17636120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]